{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:45:11Z","timestamp":1791841511968,"version":"4.3.4"},"reference-count":64,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["GM138722"],"award-info":[{"award-number":["GM138722"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["GM150502"],"award-info":[{"award-number":["GM150502"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["GM122473"],"award-info":[{"award-number":["GM122473"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50 CA196530"],"award-info":[{"award-number":["P50 CA196530"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.isci.2026.115952","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T02:32:21Z","timestamp":1777602741000},"page":"115952","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["PIP4K2A\/2B inhibitor suppresses tumor growth in a xenograft model of NSCLC"],"prefix":"10.1016","volume":"29","author":[{"given":"Zunyu","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Bosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viswanathan","family":"Muthusamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibo","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Micheli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agostino","family":"Cianciulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Beato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Van Zandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Ellman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9825-3468","authenticated-orcid":false,"given":"Ya","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.115952_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/1873-3468.14237","article-title":"Expanding role of PI5P4Ks in cancer: A promising druggable target","volume":"596","author":"Arora","year":"2022","journal-title":"FEBS Lett."},{"key":"10.1016\/j.isci.2026.115952_bib2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ceb.2021.01.012","article-title":"Emerging cell biological functions of phosphatidylinositol 5 phosphate 4 kinase","volume":"71","author":"Raghu","year":"2021","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.isci.2026.115952_bib3","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.bbalip.2015.02.014","article-title":"PIP4K and the role of nuclear phosphoinositides in tumour suppression","volume":"1851","author":"Fiume","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.isci.2026.115952_bib4","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.cell.2013.09.057","article-title":"Depletion of a putatively druggable class of phosphatidylinositol kinases inhibits growth of p53-null tumors","volume":"155","author":"Emerling","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.isci.2026.115952_bib5","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/36621","article-title":"A new pathway for synthesis of phosphatidylinositol-4,5-bisphosphate","volume":"390","author":"Rameh","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.115952_bib6","doi-asserted-by":"crossref","first-page":"20292","DOI":"10.1074\/jbc.273.32.20292","article-title":"A novel phosphatidylinositol-5-phosphate 4-kinase (phosphatidylinositol-phosphate kinase IIgamma) is phosphorylated in the endoplasmic reticulum in response to mitogenic signals","volume":"273","author":"Itoh","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.isci.2026.115952_bib7","doi-asserted-by":"crossref","first-page":"18012","DOI":"10.1016\/S0021-9258(18)38264-4","article-title":"The human erythrocyte contains two forms of phosphatidylinositol-4-phosphate 5-kinase which are differentially active toward membranes","volume":"265","author":"Bazenet","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.isci.2026.115952_bib8","doi-asserted-by":"crossref","first-page":"5080","DOI":"10.1016\/S0021-9258(18)83702-4","article-title":"Characterization and purification of membrane-associated phosphatidylinositol-4-phosphate kinase from human red blood cells","volume":"264","author":"Ling","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.isci.2026.115952_bib9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1042\/BJ20130488","article-title":"Evolutionarily conserved structural changes in phosphatidylinositol 5-phosphate 4-kinase (PI5P4K) isoforms are responsible for differences in enzyme activity and localization","volume":"454","author":"Clarke","year":"2013","journal-title":"Biochem. J."},{"key":"10.1016\/j.isci.2026.115952_bib10","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1042\/bj3460587","article-title":"Nuclear targeting of the beta isoform of type II phosphatidylinositol phosphate kinase (phosphatidylinositol 5-phosphate 4-kinase) by its alpha-helix 7","volume":"346","author":"Ciruela","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.isci.2026.115952_bib11","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.molcel.2018.03.037","article-title":"Phosphatidylinositol-5-Phosphate 4-Kinases Regulate Cellular Lipid Metabolism By Facilitating Autophagy","volume":"70","author":"Lundquist","year":"2018","journal-title":"Molecular cell"},{"key":"10.1016\/j.isci.2026.115952_bib12","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1194\/jlr.M082149","article-title":"PIP4K2A regulates intracellular cholesterol transport through modulating PI(4,5)P(2) homeostasis","volume":"59","author":"Hu","year":"2018","journal-title":"Journal of lipid research"},{"key":"10.1016\/j.isci.2026.115952_bib13","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.molcel.2014.12.007","article-title":"PI(5)P regulates autophagosome biogenesis","volume":"57","author":"Vicinanza","year":"2015","journal-title":"Molecular cell"},{"key":"10.1016\/j.isci.2026.115952_bib14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1042\/BJ20100340","article-title":"Genomic tagging reveals a random association of endogenous PtdIns5P 4-kinases IIalpha and IIbeta and a partial nuclear localization of the IIalpha isoform","volume":"430","author":"Wang","year":"2010","journal-title":"Biochem. J."},{"key":"10.1016\/j.isci.2026.115952_bib15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1042\/BJ20100341","article-title":"PIP4Kbeta interacts with and modulates nuclear localization of the high-activity PtdIns5P-4-kinase isoform PIP4Kalpha","volume":"430","author":"Bultsma","year":"2010","journal-title":"Biochem. J."},{"key":"10.1016\/j.isci.2026.115952_bib16","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.molcel.2006.07.014","article-title":"Nuclear PtdIns5P as a transducer of stress signaling: an in vivo role for PIP4Kbeta","volume":"23","author":"Jones","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1016\/j.isci.2026.115952_bib17","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1096\/fj.12-218842","article-title":"PtdIns5P is an oxidative stress-induced second messenger that regulates PKB activation","volume":"27","author":"Jones","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/j.isci.2026.115952_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2003223","article-title":"Regulation of phosphatidylinositol-5-phosphate signaling by Pin1 determines sensitivity to oxidative stress","volume":"5","author":"Keune","year":"2012","journal-title":"Sci. Signal."},{"key":"10.1016\/j.isci.2026.115952_bib19","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.devcel.2021.04.019","article-title":"PI5P4Ks drive metabolic homeostasis through peroxisome-mitochondria interplay","volume":"56","author":"Ravi","year":"2021","journal-title":"Dev. Cell"},{"key":"10.1016\/j.isci.2026.115952_bib20","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41573-022-00582-5","article-title":"Beyond PI3Ks: targeting phosphoinositide kinases in disease","volume":"22","author":"Burke","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.isci.2026.115952_bib21","doi-asserted-by":"crossref","first-page":"5080","DOI":"10.1128\/MCB.24.11.5080-5087.2004","article-title":"Increased insulin sensitivity and reduced adiposity in phosphatidylinositol 5-phosphate 4-kinase beta-\/- mice","volume":"24","author":"Lamia","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.isci.2026.115952_bib22","first-page":"7596","article-title":"Deletion of the gene Pip4k2c, a novel phosphatidylinositol kinase, results in hyperactivation of the immune system","volume":"113","author":"Shim","year":"2016","journal-title":"Proc"},{"key":"10.1016\/j.isci.2026.115952_bib23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41573-022-00571-8","article-title":"Drugging p53 in cancer: one protein, many targets","volume":"22","author":"Hassin","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.isci.2026.115952_bib24","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.chembiol.2020.02.003","article-title":"Targeting the PI5P4K Lipid Kinase Family in Cancer Using Covalent Inhibitors","volume":"27","author":"Sivakumaren","year":"2020","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.isci.2026.115952_bib25","article-title":"Pharmacological inhibition of PI5P4K\u03b1\/\u03b2 disrupts cell energy metabolism and selectively kills p53-null tumor cells","volume":"118","author":"Chen","year":"2021","journal-title":"Proc"},{"key":"10.1016\/j.isci.2026.115952_bib26","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41408-022-00747-w","article-title":"The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy","volume":"12","author":"Lima","year":"2022","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.isci.2026.115952_bib27","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/onc.2014.77","article-title":"A targeted knockdown screen of genes coding for phosphoinositide modulators identifies PIP4K2A as required for acute myeloid leukemia cell proliferation and survival","volume":"34","author":"Jude","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.isci.2026.115952_bib28","article-title":"PIP4Ks impact on PI3K, FOXP3, and UHRF1 signaling and modulate human regulatory T cell proliferation and immunosuppressive activity","volume":"118","author":"Poli","year":"2021","journal-title":"Proc"},{"key":"10.1016\/j.isci.2026.115952_bib29","doi-asserted-by":"crossref","first-page":"288","DOI":"10.21037\/tlcr.2016.06.07","article-title":"Non-small cell lung cancer: current treatment and future advances","volume":"5","author":"Zappa","year":"2016","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.isci.2026.115952_bib30","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1535-6108(03)00220-4","article-title":"Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model","volume":"4","author":"Meuwissen","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2026.115952_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0960-9822(00)00002-6","article-title":"Tumor spectrum analysis in p53-mutant mice","volume":"4","author":"Jacks","year":"1994","journal-title":"Curr. Biol."},{"key":"10.1016\/j.isci.2026.115952_bib32","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","article-title":"Tumour-associated macrophages as treatment targets in oncology","volume":"14","author":"Mantovani","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.isci.2026.115952_bib33","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/cmdc.201200585","article-title":"Carboxylic acid (bio)isosteres in drug design","volume":"8","author":"Ballatore","year":"2013","journal-title":"ChemMedChem"},{"key":"10.1016\/j.isci.2026.115952_bib34","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1038\/s41467-017-02287-5","article-title":"Dual blockade of the lipid kinase PIP4Ks and mitotic pathways leads to cancer-selective lethality","volume":"8","author":"Kitagawa","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.115952_bib35","doi-asserted-by":"crossref","first-page":"4880","DOI":"10.1021\/acs.jmedchem.0c00227","article-title":"Discovery and Structure-Activity Relationship Study of (Z)-5-Methylenethiazolidin-4-one Derivatives as Potent and Selective Pan-phosphatidylinositol 5-Phosphate 4-Kinase Inhibitors","volume":"63","author":"Manz","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.isci.2026.115952_bib36","doi-asserted-by":"crossref","first-page":"15883","DOI":"10.1021\/acs.jmedchem.1c01245","article-title":"Discovery and Characterization of the Potent and Highly Selective 1,7-Naphthyridine-Based Inhibitors BAY-091 and BAY-297 of the Kinase PIP4K2A","volume":"64","author":"Wortmann","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.isci.2026.115952_bib37","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.bbrc.2014.05.024","article-title":"Discovery and pharmacological characterization of a novel small molecule inhibitor of phosphatidylinositol-5-phosphate 4-kinase, type II, beta","volume":"449","author":"Voss","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.isci.2026.115952_bib38","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.29123","article-title":"Inhibition of PIP4K\u03b3 ameliorates the pathological effects of mutant huntingtin protein","volume":"6","author":"Al-Ramahi","year":"2017","journal-title":"eLife"},{"key":"10.1016\/j.isci.2026.115952_bib39","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1021\/acs.jmedchem.1c01819","article-title":"Development of Selective Phosphatidylinositol 5-Phosphate 4-Kinase \u03b3 Inhibitors with a Non-ATP-competitive, Allosteric Binding Mode","volume":"65","author":"Boffey","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.isci.2026.115952_bib40","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1039\/D3MD00039G","article-title":"Identification of ARUK2002821 as an isoform-selective PI5P4K\u03b1 inhibitor","volume":"14","author":"Willems","year":"2023","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.isci.2026.115952_bib41","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.str.2022.04.004","article-title":"The GTP responsiveness of PI5P4K\u03b2 evolved from a compromised trade-off between activity and specificity","volume":"30","author":"Takeuchi","year":"2022","journal-title":"Structure"},{"key":"10.1016\/j.isci.2026.115952_bib42","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.molcel.2015.12.011","article-title":"The Lipid Kinase PI5P4Kbeta Is an Intracellular GTP Sensor for Metabolism and Tumorigenesis","volume":"61","author":"Sumita","year":"2016","journal-title":"Mol. Cell"},{"key":"10.1016\/j.isci.2026.115952_bib43","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0092-8674(00)81741-9","article-title":"Structure of type IIbeta phosphatidylinositol phosphate kinase: a protein kinase fold flattened for interfacial phosphorylation","volume":"94","author":"Rao","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.isci.2026.115952_bib44","doi-asserted-by":"crossref","first-page":"10288","DOI":"10.1158\/0008-5472.CAN-10-1893","article-title":"CX-4945, an Orally Bioavailable Selective Inhibitor of Protein Kinase CK2, Inhibits Prosurvival and Angiogenic Signaling and Exhibits Antitumor Efficacy","volume":"70","author":"Siddiqui-Jain","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2026.115952_bib45","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/s41568-022-00547-1","article-title":"A timeline of tumour-associated macrophage biology","volume":"23","author":"Cassetta","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.isci.2026.115952_bib46","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41571-022-00620-6","article-title":"Clinical relevance of tumour-associated macrophages","volume":"19","author":"Pittet","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.isci.2026.115952_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008668","article-title":"The identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages","volume":"5","author":"Daigneault","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2026.115952_bib48","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1186\/s12885-015-1546-9","article-title":"M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide","volume":"15","author":"Genin","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.isci.2026.115952_bib49","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-012418-012718","article-title":"Diversity, Mechanisms, and Significance of Macrophage Plasticity","volume":"15","author":"Locati","year":"2020","journal-title":"Ann. Rev. Path."},{"key":"10.1016\/j.isci.2026.115952_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22136995","article-title":"Macrophage Polarization States in the Tumor Microenvironment","volume":"22","author":"Boutilier","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.115952_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.583084","article-title":"Tumor-Associated Macrophages in Tumor Immunity","volume":"11","author":"Pan","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.115952_bib52","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/978-1-4939-7837-3_12","article-title":"Polarizing Macrophages In Vitro","volume":"1784","author":"Huang","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.isci.2026.115952_bib53","doi-asserted-by":"crossref","first-page":"6425","DOI":"10.1002\/jcp.26429","article-title":"Macrophage plasticity, polarization, and function in health and disease","volume":"233","author":"Shapouri-Moghaddam","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.isci.2026.115952_bib54","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nrm4007","article-title":"p53 in survival, death and metabolic health: a lifeguard with a licence to kill","volume":"16","author":"Kruiswijk","year":"2015","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.isci.2026.115952_bib55","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/j.celrep.2019.04.070","article-title":"PIP4Ks Suppress Insulin Signaling through a Catalytic-Independent Mechanism","volume":"27","author":"Wang","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2026.115952_bib56","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2026.115952_bib57","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nri978","article-title":"Alternative activation of macrophages","volume":"3","author":"Gordon","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.isci.2026.115952_bib58","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41392-023-01460-1","article-title":"Angiogenic signaling pathways and anti-angiogenic therapy for cancer","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.isci.2026.115952_bib59","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.celrep.2013.11.020","article-title":"An optimized microRNA backbone for effective single-copy RNAi","volume":"5","author":"Fellmann","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2026.115952_bib60","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","article-title":"Processing of X-ray diffraction data collected in oscillation mode","volume":"276","author":"Otwinowski","year":"1997","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.isci.2026.115952_bib61","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1107\/S0907444910045749","article-title":"Overview of the CCP4 suite and current developments","volume":"67","author":"Winn","year":"2011","journal-title":"Acta crystallographica. Section D Biolog. Crystallography"},{"key":"10.1016\/j.isci.2026.115952_bib62","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1107\/S0907444904011679","article-title":"PRODRG: a tool for high-throughput crystallography of protein-ligand complexes","volume":"60","author":"Schuttelkopf","year":"2004","journal-title":"Acta crystallographica. Section D, Biolog. Crystallo."},{"key":"10.1016\/j.isci.2026.115952_bib63","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta crystallographica. Section D, Biolog. Crystallography"},{"key":"10.1016\/j.isci.2026.115952_bib64","first-page":"8711","article-title":"Mechanism of substrate specificity of phosphatidylinositol phosphate kinases","volume":"113","author":"Muftuoglu","year":"2016","journal-title":"Proc"}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226013271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226013271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:51:24Z","timestamp":1791838284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226013271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":64,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2589004226013271"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.115952","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PIP4K2A\/2B inhibitor suppresses tumor growth in a xenograft model of NSCLC","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.115952","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115952"}}